Rezolute

Rezolute Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism

On June 20, don’t miss Neuroendocrine Cancer Foundation's 2026 Annual Patient Conference, a free online event for indivi...
06/18/2026

On June 20, don’t miss Neuroendocrine Cancer Foundation's 2026 Annual Patient Conference, a free online event for individuals and families living with tumors (NETs).

During the event, 20 leading NET experts will share insights into diagnosis, treatment options, and disease monitoring.

Register for free: https://bit.ly/3QTf5XD

Congratulations to Enola Wright, Founder of the Insulinoma Charity  and Insulinoma Awareness, on receiving the British E...
06/17/2026

Congratulations to Enola Wright, Founder of the Insulinoma Charity and Insulinoma Awareness, on receiving the British Empire Medal (BEM).

This meaningful honor recognizes her tireless dedication to the insulinoma community and her leadership in building a strong global network of patients, caregivers, advocates, and healthcare professionals. We celebrate her achievement and the impact of her work.

Learn more: https://bit.ly/4fM1BHj

That’s a wrap on  ! Over the past few days, we've had the opportunity to connect with healthcare professionals, share da...
06/16/2026

That’s a wrap on !

Over the past few days, we've had the opportunity to connect with healthcare professionals, share data, and engage in important conversations about the future of treating .

Thank you to everyone who visited our booth, attended our presentations, and spent time connecting with our team.

We look forward to continuing these important conversations beyond the meeting.

Reminder: Rezolute’s final poster presentation at   is coming up!Davelyn Eaves Hood, MD, MBA, our VP of Medical and Pati...
06/15/2026

Reminder: Rezolute’s final poster presentation at is coming up!

Davelyn Eaves Hood, MD, MBA, our VP of Medical and Patient Affairs, will be presenting 𝘖𝘶𝘵𝘤𝘰𝘮𝘦𝘴 𝘪𝘯 𝘊𝘰𝘯𝘨𝘦𝘯𝘪𝘵𝘢𝘭 𝘏𝘺𝘱𝘦𝘳𝘪𝘯𝘴𝘶𝘭𝘪𝘯𝘪𝘴𝘮: 𝘈 𝘚𝘺𝘴𝘵𝘦𝘮𝘢𝘵𝘪𝘤 𝘙𝘦𝘷𝘪𝘦𝘸 at 12 PM CDT on the poster floor.

Join her there and then stop by Booth #4826 afterward to say hello to the rest of our team.

What's one thing you wish more people knew about hyperinsulinism?We're sharing perspectives from our team at   and highl...
06/14/2026

What's one thing you wish more people knew about hyperinsulinism?

We're sharing perspectives from our team at and highlighting the importance of continued research, awareness, and support for the community. Together, we’re working to improve quality of life for patients and their families.

Learn more: https://bit.ly/4gqlkMO

We kicked off day 2 at   with a visit to some of our advocacy partners from Congenital Hyperinsulinism International.We'...
06/14/2026

We kicked off day 2 at with a visit to some of our advocacy partners from Congenital Hyperinsulinism International.

We're incredibly grateful for their partnership and shared commitment to improving the lives of individuals and families impacted by . It’s always a pleasure to connect with their team in person to explore how we can help shape a better future for care.

We are closing out a great first day at  ! Thank you to everyone who has stopped by booth  #4826 so far to discuss the l...
06/13/2026

We are closing out a great first day at ! Thank you to everyone who has stopped by booth #4826 so far to discuss the latest in .

We're inspired by the conversations we’ve had and by the endocrinology community's commitment to advancing care. Thank you to the Endocrine Society for bringing together thousands of researchers, clinicians, and innovators driving progress in the space.

Come visit us tomorrow, right across from the Bark Park!

Don’t miss our oral presentation and two posters today at  . Presentation details:𝘖𝘳𝘢𝘭 𝘗𝘳𝘦𝘴𝘦𝘯𝘵𝘢𝘵𝘪𝘰𝘯Presentation Title: E...
06/13/2026

Don’t miss our oral presentation and two posters today at . Presentation details:

𝘖𝘳𝘢𝘭 𝘗𝘳𝘦𝘴𝘦𝘯𝘵𝘢𝘵𝘪𝘰𝘯

Presentation Title: Ersodetug (RZ358) in Congenital Hyperinsulinism: Top-Line Results from a Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study (sunRIZE)
Poster Number: ORF10-06
Time: 2:30 PM CDT
Location: Room W183BC

𝘗𝘰𝘴𝘵𝘦𝘳 𝘗𝘳𝘦𝘴𝘦𝘯𝘵𝘢𝘵𝘪𝘰𝘯𝘴

Presentation Title: A Case Series on the Compassionate Use of Ersodetug, an Insulin Receptor Modulating Antibody, in Patients with Refractory Hypoglycemia Due to Malignant Insulin-Secreting Tumors
Poster Number: SAT-087
Time: 12:15 PM CDT
Location: Poster Floor

Presentation Title: Association of Early-Life Hypoglycemia with Later Neurological Outcomes in Congenital Hyperinsulinism: A US Claims-Based Study
Poster Number: SAT-221
Time: 12:15 PM CDT
Location: Poster Floor

Join us to learn more and connect with our team at booth #4826 afterward for discussion and questions.

ENDO details: https://bit.ly/4uo6NEN

Our team is officially on the ground at   in Chicago! We’re excited to connect with healthcare professionals, researcher...
06/13/2026

Our team is officially on the ground at in Chicago! We’re excited to connect with healthcare professionals, researchers, and colleagues from across the endocrinology field.

Visit us at booth #4826 to:

· Meet or reconnect with the Rezolute team
· Learn about our work in and
· Discuss the future of care

If you're attending, stop by and say hello – we'd love to see you.

Learn more about ENDO: https://bit.ly/4uo6NEN

We’re looking forward to kicking off   soon!Tomorrow, we start strong with one oral presentation and two posters, and ou...
06/12/2026

We’re looking forward to kicking off soon!

Tomorrow, we start strong with one oral presentation and two posters, and our team is excited to exchange insights with the endocrinology community throughout the meeting.

Be sure to join our presentations to learn more about the unmet need in and potential advancements in treatment, and stop by booth #4826 afterward to continue the conversation with our team.

View our presentation details here: https://bit.ly/4uSZ1Eb

Address

275 Shoreline Drive, Ste. 500
Redwood City, CA
94065

Alerts

Be the first to know and let us send you an email when Rezolute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Rezolute:

Share